Anticonvulsive Drug Use in Status Therapy: Adults

Beuchat, I.; Rossetti, A. O.

doi:10.1007/978-3-319-56015-1_370-1

I. Beuchat⁶ &
A. O. Rossetti⁶

184 Accesses

Abstract

In adults, status epilepticus represents after stroke one of the most frequent neurological emergencies. Depending on the type and duration of seizures, it can induce considerable morbidity and mortality, therefore requiring immediate management. International guidelines recommend a stepwise approach, where treatment lines are used sequentially and additionally. In early status epilepticus, benzodiazepines represent the first line of treatment, typically followed by intravenous antiepileptic drugs in established status epilepticus. If seizures continue after this stage, the situation is labelled as refractory status epilepticus; intravenous anesthetics with coma induction (third line treatment) are advocated, particularly in patients not protecting their airways and showing generalized-convulsive or nonconvulsive status epilepticus in coma. Additional treatment lines, such as ketogenic diet, ketamine, corticosteroids, may be prescribed in super-refractory status epilepticus, a condition resulting for treatment resistance to at least one trial of general anesthetics.

Besides the first-line treatment, evidence regarding medications commonly used in status epilepticus is quite limited, especially in later stages. In this chapter, we describe pharmacological compounds according to this stepwise approach, considering existing evidence, advantages, and drawbacks of each molecule.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

Agarwal P, Kumar N, Chandra R, Gupta G, Antony AR, Garg N. Randomized study of intravenous valproate and phenytoin in status epilepticus. Seizure-Eur J Epilepsy. 2007;16(6):527–32. https://doi.org/10.1016/j.seizure.2007.04.012.
Article Google Scholar
Aicua-Rapun I, Andre P, Rossetti AO, Decosterd LA, Buclin T, Novy J. Intravenous brivaracetam in status epilepticus: correlation between loading dose, plasma levels and clinical response. Epilepsy Res. 2019;149:88–91. https://doi.org/10.1016/j.eplepsyres.2018.12.001.
Article CAS PubMed Google Scholar
Alldredge BK, Gelb AM, Isaacs SM, Corry MD, Allen F, Ulrich S, et al. A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med. 2001;345(9):631–7. https://doi.org/10.1056/NEJMoa002141.
Article CAS PubMed Google Scholar
Alvarez V, Januel JM, Burnand B, Rossetti AO. Second-line status epilepticus treatment: comparison of phenytoin, valproate, and levetiracetam. Epilepsia. 2011;52(7):1292–6. https://doi.org/10.1111/j.1528-1167.2011.03056.x.
Article CAS PubMed Google Scholar
Alvarez V, Lee JW, Drislane FW, Westover MB, Novy J, Dworetzky BA, et al. Practice variability and efficacy of clonazepam, lorazepam, and midazolam in status epilepticus: a multicenter comparison. Epilepsia. 2015;56(8):1275–85. https://doi.org/10.1111/epi.13056.
Article CAS PubMed PubMed Central Google Scholar
Alvarez V, Lee JW, Westover MB, Drislane FW, Novy J, Faouzi M, et al. Therapeutic coma for status epilepticus: differing practices in a prospective multicenter study. Neurology. 2016;87(16):1650–9. https://doi.org/10.1212/WNL.0000000000003224.
Article CAS PubMed PubMed Central Google Scholar
Appleton RE, Gill A. Adverse events associated with intravenous phenytoin in children: a prospective study. Seizure. 2003;12(6):369–72.
Article Google Scholar
Appleton R, Sweeney A, Choonara I, Robson J, Molyneux E. Lorazepam versus diazepam in the acute treatment of epileptic seizures and status epilepticus. Dev Med Child Neurol. 1995;37(8):682–8.
Article CAS Google Scholar
Belcastro V, Vidale S, Pierguidi L, Sironi L, Tancredi L, Striano P, et al. Intravenous lacosamide as treatment option in post-stroke non convulsive status epilepticus in the elderly: a proof-of-concept, observational study. Seizure. 2013;22(10):905–7. https://doi.org/10.1016/j.seizure.2013.07.011.
Article PubMed Google Scholar
Bellante F, Legros B, Depondt C, Creteur J, Taccone FS, Gaspard N. Midazolam and thiopental for the treatment of refractory status epilepticus: a retrospective comparison of efficacy and safety. J Neurol. 2016;263(4):799–806. https://doi.org/10.1007/s00415-016-8074-7.
Article CAS PubMed Google Scholar
Bensalem MK, Fakhoury TA. Topiramate and status epilepticus: report of three cases. Epilepsy Behav. 2003;4(6):757–60.
Article Google Scholar
Berlin A, Dahlstrom H. Pharmacokinetics of the anticonvulsant drug clonazepam evaluated from single oral and intravenous doses and by repeated oral administration. Eur J Clin Pharmacol. 1975;9(2–3):155–9.
Article CAS Google Scholar
Betjemann JP, Lowenstein DH. Status epilepticus in adults. Lancet Neurol. 2015;14(6):615–24. https://doi.org/10.1016/S1474-4422(15)00042-3.
Article PubMed Google Scholar
Beuchat I, Novy J, Rossetti AO. Newer antiepileptic drugs in status epilepticus: prescription trends and outcomes in comparison with traditional agents. CNS Drugs. 2017;31(4):327–34. https://doi.org/10.1007/s40263-017-0424-1.
Article CAS PubMed Google Scholar
Beuchat I, Novy J, Rossetti AO. Newer antiepileptic drugs for status epilepticus in adults: what’s the evidence? CNS Drugs. 2018;32(3):259–67. https://doi.org/10.1007/s40263-018-0509-5.
Article CAS PubMed Google Scholar
Bleck T, Cock H, Chamberlain J, Cloyd J, Connor J, Elm J, et al. The established status epilepticus trial 2013. Epilepsia. 2013;54(Suppl 6):89–92. https://doi.org/10.1111/epi.12288.
Article CAS PubMed PubMed Central Google Scholar
Brigo F, Trinka E. Randomized controlled trials in status epilepticus: size matters. Epilepsia. 2017;58(5):915. https://doi.org/10.1111/epi.13775.
Article PubMed Google Scholar
Brigo F, Storti M, Del Felice A, Fiaschi A, Bongiovanni LG. IV Valproate in generalized convulsive status epilepticus: a systematic review. Eur J Neurol. 2012;19(9):1180–91. https://doi.org/10.1111/j.1468-1331.2011.03606.x.
Article CAS PubMed Google Scholar
Brigo F, Bragazzi N, Nardone R, Trinka E. Direct and indirect comparison meta-analysis of levetiracetam versus phenytoin or valproate for convulsive status epilepticus. Epilepsy Behav. 2016;64(Pt A):110–5. https://doi.org/10.1016/j.yebeh.2016.09.030.
Article PubMed Google Scholar
Brophy GM, Bell R, Claassen J, Alldredge B, Bleck TP, Glauser T, et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care. 2012;17(1):3–23. https://doi.org/10.1007/s12028-012-9695-z.
Article PubMed Google Scholar
Browne TR. The pharmacokinetics of agents used to treat status epilepticus. Neurology. 1990;40(5 Suppl 2):28–32.
CAS PubMed Google Scholar
Cervenka MC, Hocker S, Koenig M, Bar B, Henry-Barron B, Kossoff EH, et al. Phase I/II multicenter ketogenic diet study for adult superrefractory status epilepticus. Neurology. 2017;88(10):938–43. https://doi.org/10.1212/WNL.0000000000003690.
Article CAS PubMed PubMed Central Google Scholar
Chakravarthi S, Goyal MK, Modi M, Bhalla A, Singh P. Levetiracetam versus phenytoin in management of status epilepticus. J Clin Neurosci. 2015;22(6):959–63. https://doi.org/10.1016/j.jocn.2014.12.013.
Article CAS PubMed Google Scholar
Chen JW, Wasterlain CG. Status epilepticus: pathophysiology and management in adults. Lancet Neurol. 2006;5(3):246–56. https://doi.org/10.1016/S1474-4422(06)70374-X.
Article PubMed Google Scholar
Claassen J, Hirsch LJ, Emerson RG, Bates JE, Thompson TB, Mayer SA. Continuous EEG monitoring and midazolam infusion for refractory nonconvulsive status epilepticus. Neurology. 2001;57(6):1036–42.
Article CAS Google Scholar
Claassen J, Hirsch LJ, Emerson RG, Mayer SA. Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review. Epilepsia. 2002;43(2):146–53.
Article CAS Google Scholar
Claassen J, Taccone FS, Horn P, Holtkamp M, Stocchetti N, Oddo M, et al. Recommendations on the use of EEG monitoring in critically ill patients: consensus statement from the neurointensive care section of the ESICM. Intensive Care Med. 2013;39(8):1337–51. https://doi.org/10.1007/s00134-013-2938-4.
Article CAS PubMed Google Scholar
Claassen J, Riviello JJ Jr, Silbergleit R. Emergency neurological life support: status epilepticus. Neurocrit Care. 2015;23(Suppl 2):S136–42. https://doi.org/10.1007/s12028-015-0172-3.
Article CAS PubMed Google Scholar
Cranford RE, Leppik IE, Patrick B, Anderson CB, Kostick B. Intravenous phenytoin in acute treatment of seizures. Neurology. 1979;29(11):1474–9. https://doi.org/10.1212/Wnl.29.11.1474.
Article CAS PubMed Google Scholar
Cremer OL, Moons KG, Bouman EA, Kruijswijk JE, de Smet AM, Kalkman CJ. Long-term propofol infusion and cardiac failure in adult head-injured patients. Lancet. 2001;357(9250):117–8. https://doi.org/10.1016/S0140-6736(00)03547-9.
Article CAS PubMed Google Scholar
DeLorenzo RJ, Garnett LK, Towne AR, Waterhouse EJ, Boggs JG, Morton L, et al. Comparison of status epilepticus with prolonged seizure episodes lasting from 10 to 29 minutes. Epilepsia. 1999;40(2):164–9.
Article CAS Google Scholar
Denzel D, Burstein AH. Midazolam in refractory status epilepticus. Ann Pharmacother. 1996;30(12):1481–3. https://doi.org/10.1177/106002809603001217.
Article CAS PubMed Google Scholar
Fernandez A, Lantigua H, Lesch C, Shao B, Foreman B, Schmidt JM, et al. High-dose midazolam infusion for refractory status epilepticus. Neurology. 2014;82(4):359–65. https://doi.org/10.1212/WNL.0000000000000054.
Article CAS PubMed PubMed Central Google Scholar
Fischer JH, Patel TV, Fischer PA. Fosphenytoin: clinical pharmacokinetics and comparative advantages in the acute treatment of seizures. Clin Pharmacokinet. 2003;42(1):33–58. https://doi.org/10.2165/00003088-200342010-00002.
Article CAS PubMed Google Scholar
Garces M, Villanueva V, Mauri JA, Suller A, Garcia C, Lopez Gonzalez FJ, et al. Factors influencing response to intravenous lacosamide in emergency situations: LACO-IV study. Epilepsy Behav. 2014;36:144–52. https://doi.org/10.1016/j.yebeh.2014.05.015.
Article PubMed Google Scholar
Gaspard N, Foreman B, Judd LM, Brenton JN, Nathan BR, McCoy BM, et al. Intravenous ketamine for the treatment of refractory status epilepticus: a retrospective multicenter study. Epilepsia. 2013;54(8):1498–503. https://doi.org/10.1111/epi.12247.
Article CAS PubMed PubMed Central Google Scholar
Gaspard N, Foreman BP, Alvarez V, Cabrera Kang C, Probasco JC, Jongeling AC, et al. New-onset refractory status epilepticus: etiology, clinical features, and outcome. Neurology. 2015;85(18):1604–13. https://doi.org/10.1212/WNL.0000000000001940.
Article PubMed PubMed Central Google Scholar
Gilad R, Izkovitz N, Dabby R, Rapoport A, Sadeh M, Weller B, et al. Treatment of status epilepticus and acute repetitive seizures with i.v. valproic acid vs phenytoin. Acta Neurol Scand. 2008;118(5):296–300. https://doi.org/10.1111/j.1600-0404.2008.01097.x.
Article CAS PubMed Google Scholar
Gillard M, Fuks B, Leclercq K, Matagne A. Binding characteristics of brivaracetam, a selective, high affinity SV2A ligand in rat, mouse and human brain: relationship to anti-convulsant properties. Eur J Pharmacol. 2011;664(1–3):36–44. https://doi.org/10.1016/j.ejphar.2011.04.064.
Article CAS PubMed Google Scholar
Glauser T, Shinnar S, Gloss D, Alldredge B, Arya R, Bainbridge J, et al. Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the guideline Committee of the American Epilepsy Society. Epilepsy Curr. 2016;16(1):48–61. https://doi.org/10.5698/1535-7597-16.1.48.
Article PubMed PubMed Central Google Scholar
Goodwin H, Hinson HE, Shermock KM, Karanjia N, Lewin JJ 3rd. The use of lacosamide in refractory status epilepticus. Neurocrit Care. 2011;14(3):348–53. https://doi.org/10.1007/s12028-010-9501-8.
Article CAS PubMed Google Scholar
Greenfield LJ Jr. Molecular mechanisms of antiseizure drug activity at GABAA receptors. Seizure. 2013;22(8):589–600. https://doi.org/10.1016/j.seizure.2013.04.015.
Article PubMed PubMed Central Google Scholar
Guidelines for epidemiologic studies on epilepsy. Commission on Epidemiology and Prognosis, International League Against Epilepsy. Epilepsia. 1993. 34(4):592–596.
Google Scholar
Gujjar AR, Nandhagopal R, Jacob PC, Al-Hashim A, Al-Amrani K, Ganguly SS, et al. Intravenous levetiracetam vs phenytoin for status epilepticus and cluster seizures: a prospective, randomized study. Seizure. 2017;49:8–12. https://doi.org/10.1016/j.seizure.2017.05.001.
Article PubMed Google Scholar
Hijazi Y, Bodonian C, Bolon M, Salord F, Boulieu R. Pharmacokinetics and haemodynamics of ketamine in intensive care patients with brain or spinal cord injury. Br J Anaesth. 2003;90(2):155–60.
Article CAS Google Scholar
Hocker S. Anesthetic drugs for the treatment of status epilepticus. Epilepsia. 2018;59(Suppl 2):188–92. https://doi.org/10.1111/epi.14498.
Article PubMed Google Scholar
Hofler J, Trinka E. Lacosamide as a new treatment option in status epilepticus. Epilepsia. 2013;54(3):393–404. https://doi.org/10.1111/epi.12058.
Article CAS PubMed Google Scholar
Hofler J, Unterberger I, Dobesberger J, Kuchukhidze G, Walser G, Trinka E. Intravenous lacosamide in status epilepticus and seizure clusters. Epilepsia. 2011;52(10):e148–52. https://doi.org/10.1111/j.1528-1167.2011.03204.x.
Article CAS PubMed Google Scholar
Hofler J, Rohracher A, Kalss G, Zimmermann G, Dobesberger J, Pilz G, et al. (S)-Ketamine in refractory and super-refractory status epilepticus: a retrospective study. CNS Drugs. 2016;30(9):869–76. https://doi.org/10.1007/s40263-016-0371-2.
Article CAS PubMed PubMed Central Google Scholar
Holtkamp M. Pharmacotherapy for refractory and super-refractory status epilepticus in adults. Drugs. 2018;78(3):307–26. https://doi.org/10.1007/s40265-017-0859-1.
Article CAS PubMed Google Scholar
Hottinger A, Sutter R, Marsch S, Ruegg S. Topiramate as an adjunctive treatment in patients with refractory status epilepticus: an observational cohort study. CNS Drugs. 2012;26(9):761–72. https://doi.org/10.2165/11633090-000000000-00000.
Article CAS PubMed Google Scholar
Iyer VN, Hoel R, Rabinstein AA. Propofol infusion syndrome in patients with refractory status epilepticus: an 11-year clinical experience. Crit Care Med. 2009;37(12):3024–30. https://doi.org/10.1097/CCM.0b013e3181b08ac7.
Article CAS PubMed Google Scholar
Janz D. Historical vignette: medical treatment of status epilepticus. Epilepsia. 2013;54(Suppl 6):3–10. https://doi.org/10.1111/epi.12264.
Article CAS PubMed Google Scholar
Jaques L, Rossetti AO. Newer antiepileptic drugs in the treatment of status epilepticus: impact on prognosis. Epilepsy Behav. 2012;24(1):70–3. https://doi.org/10.1016/j.yebeh.2012.02.026.
Article PubMed Google Scholar
Jones S, Pahl C, Trinka E, Nashef L. A protocol for the inhospital emergency drug management of convulsive status epilepticus in adults. Pract Neurol. 2014;14(3):194–7. https://doi.org/10.1136/practneurol-2013-000712.
Article PubMed Google Scholar
Kalss G, Rohracher A, Leitinger M, Georg P, Novak H, Neuray C, Kreidenhuber R, Höfler J, Kuchukhidze G, Trinka E. Intravenous brivaracetam in status epilepticus- a retrospectie single centre study. Epilepsia. 2018;. In press
Google Scholar
Kapur J, Macdonald RL. Rapid seizure-induced reduction of benzodiazepine and Zn2+ sensitivity of hippocampal dentate granule cell GABAA receptors. J Neurosci. 1997;17(19):7532–40.
Article CAS Google Scholar
Kapur J, Elm J, Chamberlain JM, Barsan W, Cloyd J, Lowenstein D, et al. NETT and PECARN investigators. Randomized trial of three anticonvulsant medications for status epilepticus. N Engl J Med. 2019;381(22):2103–113.
Google Scholar
Kellinghaus C, Berning S, Immisch I, Larch J, Rosenow F, Rossetti AO, et al. Intravenous lacosamide for treatment of status epilepticus. Acta Neurol Scand. 2011;123(2):137–41. https://doi.org/10.1111/j.1600-0404.2010.01423.x.
Article CAS PubMed Google Scholar
Kellinghaus C, Berning S, Stogbauer F. Intravenous lacosamide or phenytoin for treatment of refractory status epilepticus. Acta Neurol Scand. 2014;129(5):294–9. https://doi.org/10.1111/ane.12174.
Article CAS PubMed Google Scholar
Kellinghaus C, Rossetti AO, Trinka E, Lang N, May TW, Unterberger I, et al. Factors predicting cessation of status epilepticus in clinical practice: data from a prospective observational registry (SENSE). Ann Neurol. 2019;85(3):421–32. https://doi.org/10.1002/ana.25416.
Article CAS PubMed Google Scholar
Kotani Y, Shimazawa M, Yoshimura S, Iwama T, Hara H. The experimental and clinical pharmacology of propofol, an anesthetic agent with neuroprotective properties. CNS Neurosci Ther. 2008;14(2):95–106. https://doi.org/10.1111/j.1527-3458.2008.00043.x.
Article CAS PubMed PubMed Central Google Scholar
Krajcova A, Waldauf P, Andel M, Duska F. Propofol infusion syndrome: a structured review of experimental studies and 153 published case reports. Crit Care. 2015;19:398. https://doi.org/10.1186/s13054-015-1112-5.
Article PubMed PubMed Central Google Scholar
Legros B, Depondt C, Levy-Nogueira M, Ligot N, Mavroudakis N, Naeije G, et al. Intravenous lacosamide in refractory seizure clusters and status epilepticus: comparison of 200 and 400 mg loading doses. Neurocrit Care. 2014;20(3):484–8. https://doi.org/10.1007/s12028-013-9882-6.
Article CAS PubMed Google Scholar
Leppik IE, Derivan AT, Homan RW, Walker J, Ramsay RE, Patrick B. Double-blind study of lorazepam and diazepam in status epilepticus. JAMA. 1983a;249(11):1452–4.
Article CAS Google Scholar
Leppik IE, Patrick BK, Cranford RE. Treatment of acute seizures and status epilepticus with intravenous phenytoin. Adv Neurol. 1983b;34:447–51.
CAS PubMed Google Scholar
Lowenstein DH, Bleck T, Macdonald RL. It’s time to revise the definition of status epilepticus. Epilepsia. 1999;40(1):120–2.
Article CAS Google Scholar
Madzar D, Kuramatsu JB, Gerner ST, Huttner HB. Assessing the value of topiramate in refractory status epilepticus. Seizure. 2016;38:7–10. https://doi.org/10.1016/j.seizure.2016.03.003.
Article PubMed Google Scholar
Marchi NA, Novy J, Faouzi M, Stahli C, Burnand B, Rossetti AO. Status epilepticus: impact of therapeutic coma on outcome. Crit Care Med. 2015;43(5):1003–9. https://doi.org/10.1097/CCM.0000000000000881.
Article PubMed Google Scholar
Mayer SA, Claassen J, Lokin J, Mendelsohn F, Dennis LJ, Fitzsimmons BF. Refractory status epilepticus: frequency, risk factors, and impact on outcome. Arch Neurol. 2002;59(2):205–10.
Article Google Scholar
Meierkord H, Boon P, Engelsen B, Gocke K, Shorvon S, Tinuper P, et al. EFNS guideline on the management of status epilepticus in adults. Eur J Neurol. 2010;17(3):348–55. https://doi.org/10.1111/j.1468-1331.2009.02917.x.
Article CAS PubMed Google Scholar
Miro J, Toledo M, Santamarina E, Ricciardi AC, Villanueva V, Pato A, et al. Efficacy of intravenous lacosamide as an add-on treatment in refractory status epilepticus: a multicentric prospective study. Seizure. 2013;22(1):77–9. https://doi.org/10.1016/j.seizure.2012.10.004.
Article CAS PubMed Google Scholar
Mirrakhimov AE, Voore P, Halytskyy O, Khan M, Ali AM. Propofol infusion syndrome in adults: a clinical update. Crit Care Res Prac. 2015;2015:260385. https://doi.org/10.1155/2015/260385.
Article Google Scholar
Misra UK, Kalita J. A comparison of four antiepileptic drugs in status epilepticus: experience from India. Int J Neurosci. 2016;126(11):1013–9. https://doi.org/10.3109/00207454.2015.1095743.
Article CAS PubMed Google Scholar
Misra UK, Kalita J, Patel R. Sodium valproate vs phenytoin in status epilepticus: a pilot study. Neurology. 2006;67(2):340–2. https://doi.org/10.1212/01.wnl.0000224880.35053.26.
Article CAS PubMed Google Scholar
Misra UK, Kalita J, Maurya PK. Levetiracetam versus lorazepam in status epilepticus: a randomized, open labeled pilot study. J Neurol. 2012;259(4):645–8. https://doi.org/10.1007/s00415-011-6227-2.
Article CAS PubMed Google Scholar
Misra UK, Dubey D, Kalita J. A randomized controlled trial of lacosamide versus sodium valproate in status epilepticus. Epilepsia. 2017; https://doi.org/10.1111/epi.13706.
Mundlamuri RC, Sinha S, Subbakrishna DK, Prathyusha PV, Nagappa M, Bindu PS, et al. Management of generalised convulsive status epilepticus (SE): a prospective randomised controlled study of combined treatment with intravenous lorazepam with either phenytoin, sodium valproate or levetiracetam – pilot study. Epilepsy Res. 2015;114:52–8. https://doi.org/10.1016/j.eplepsyres.2015.04.013.
Article CAS PubMed Google Scholar
Navarro V, Dagron C, Elie C, Lamhaut L, Demeret S, Urien S, et al. Prehospital treatment with levetiracetam plus clonazepam or placebo plus clonazepam in status epilepticus (SAMUKeppra): a randomised, double-blind, phase 3 trial. Lancet Neurol. 2016;15(1):47–55. https://doi.org/10.1016/S1474-4422(15)00296-3.
Article CAS PubMed Google Scholar
Naylor DE, Liu H, Wasterlain CG. Trafficking of GABA(A) receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus. J Neurosci. 2005;25(34):7724–33. https://doi.org/10.1523/JNEUROSCI.4944-04.2005.
Article CAS PubMed PubMed Central Google Scholar
Nicolas JM, Hannestad J, Holden D, Kervyn S, Nabulsi N, Tytgat D, et al. Brivaracetam, a selective high-affinity synaptic vesicle protein 2A (SV2A) ligand with preclinical evidence of high brain permeability and fast onset of action. Epilepsia. 2016;57(2):201–9. https://doi.org/10.1111/epi.13267.
Article CAS PubMed Google Scholar
Niquet J, Suchomelova L, Thompson K, Klitgaard H, Matagne A, Wasterlain C. Acute and long-term effects of brivaracetam and brivaracetam-diazepam combinations in an experimental model of status epilepticus. Epilepsia. 2017;58(7):1199–207. https://doi.org/10.1111/epi.13787.
Article CAS PubMed PubMed Central Google Scholar
Novy J, Rossetti AO. Oral pregabalin as an add-on treatment for status epilepticus. Epilepsia. 2010;51(10):2207–10. https://doi.org/10.1111/j.1528-1167.2010.02646.x.
Article CAS PubMed Google Scholar
Novy J, Logroscino G, Rossetti AO. Refractory status epilepticus: a prospective observational study. Epilepsia. 2010;51(2):251–6. https://doi.org/10.1111/j.1528-1167.2009.02323.x.
Article PubMed Google Scholar
Pantazou V, Novy J, Rossetti AO. Intravenous corticosteroids as an adjunctive treatment for refractory and super-refractory status epilepticus: an observational cohort study. CNS Drugs. 2019;33(2):187–92. https://doi.org/10.1007/s40263-018-0600-y.
Article CAS PubMed Google Scholar
Parviainen I, Uusaro A, Kalviainen R, Kaukanen E, Mervaala E, Ruokonen E. High-dose thiopental in the treatment of refractory status epilepticus in intensive care unit. Neurology. 2002;59(8):1249–51.
Article CAS Google Scholar
Patsalos PN. The clinical pharmacology profile of the new antiepileptic drug perampanel: a novel noncompetitive AMPA receptor antagonist. Epilepsia. 2015;56(1):12–27. https://doi.org/10.1111/epi.12865.
Article CAS PubMed Google Scholar
Perrenoud M, Andre P, Alvarez V, Stahli C, Decosterd LA, Rossetti AO, et al. Intravenous lacosamide in status epilepticus: correlation between loading dose, serum levels, and clinical response. Epilepsy Res. 2017;135:38–42. https://doi.org/10.1016/j.eplepsyres.2017.05.007.
Article CAS PubMed Google Scholar
Power KN, Flaatten H, Gilhus NE, Engelsen BA. Propofol treatment in adult refractory status epilepticus. Mortality risk and outcome. Epilepsy Res. 2011;94(1–2):53–60. https://doi.org/10.1016/j.eplepsyres.2011.01.006.
Article CAS PubMed Google Scholar
Prasad M, Krishnan PR, Sequeira R, Al-Roomi K. Anticonvulsant therapy for status epilepticus. Cochrane Database Syst Rev. 2014;9:CD003723. https://doi.org/10.1002/14651858.CD003723.pub3.
Article Google Scholar
Ramael S, Daoust A, Otoul C, Toublanc N, Troenaru M, Lu ZS, et al. Levetiracetam intravenous infusion: a randomized, placebo-controlled safety and pharmacokinetic study. Epilepsia. 2006a;47(7):1128–35. https://doi.org/10.1111/j.1528-1167.2006.00586.x.
Article CAS PubMed Google Scholar
Ramael S, De Smedt F, Toublanc N, Otoul C, Boulanger P, Riethuisen JM, et al. Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects. Clin Ther. 2006b;28(5):734–44. https://doi.org/10.1016/j.clinthera.2006.05.004.
Article CAS PubMed Google Scholar
Rantsch K, Walter U, Wittstock M, Benecke R, Rosche J. Treatment and course of different subtypes of status epilepticus. Epilepsy Res. 2013;107(1–2):156–62. https://doi.org/10.1016/j.eplepsyres.2013.08.001.
Article CAS PubMed Google Scholar
Reddy DS, Estes WA. Clinical potential of neurosteroids for CNS disorders. Trends Pharmacol Sci. 2016;37(7):543–61. https://doi.org/10.1016/j.tips.2016.04.003.
Article CAS PubMed PubMed Central Google Scholar
Redecker J, Wittstock M, Benecke R, Rosche J. Efficacy of perampanel in refractory nonconvulsive status epilepticus and simple partial status epilepticus. Epilepsy Behav. 2015;45:176–9. https://doi.org/10.1016/j.yebeh.2015.01.036.
Article PubMed Google Scholar
Remi C, Lorenzl S, Vyhnalek B, Rastorfer K, Feddersen B. Continuous subcutaneous use of levetiracetam: a retrospective review of tolerability and clinical effects. J Pain Palliat Care Pharmacother. 2014;28(4):371–7. https://doi.org/10.3109/15360288.2014.959234.
Article PubMed Google Scholar
Rohracher A, Hofler J, Kalss G, Leitinger M, Kuchukhidze G, Deak I, et al. Perampanel in patients with refractory and super-refractory status epilepticus in a neurological intensive care unit. Epilepsy Behav. 2015;49:354–8. https://doi.org/10.1016/j.yebeh.2015.04.005.
Article CAS PubMed Google Scholar
Rohracher A, Zimmermann G, Villanueva V, Garamendi I, Sander JW, Wehner T, et al. Perampanel in routine clinical use across Europe: pooled, multicenter, observational data. Epilepsia. 2018;59(9):1727–39. https://doi.org/10.1111/epi.14520.
Article CAS PubMed Google Scholar
Rosche J, Kampf C, Benecke R. Possible effect of perampanel on focal status epilepticus after generalized tonic-clonic status epilepticus. Acta Neurol Belg. 2014;114(3):243–4. https://doi.org/10.1007/s13760-013-0225-3.
Article PubMed Google Scholar
Rosenthal ES, Claassen J, Wainwright MS, Husain AM, Vaitkevicius H, Raines S, et al. Brexanolone as adjunctive therapy in super-refractory status epilepticus. Ann Neurol. 2017;82(3):342–52. https://doi.org/10.1002/ana.25008.
Article CAS PubMed PubMed Central Google Scholar
Rossetti AO. Treatment options in the management of status epilepticus. Curr Treat Options Neurol. 2010;12(2):100–12. https://doi.org/10.1007/s11940-010-0060-2.
Article PubMed Google Scholar
Rossetti AO. Are newer AEDs better than the classic ones in the treatment of status epilepticus? J Clin Neurophysiol. 2016;33(1):18–21. https://doi.org/10.1097/WNP.0000000000000211.
Article PubMed Google Scholar
Rossetti AO, Reichhart MD, Schaller MD, Despland PA, Bogousslavsky J. Propofol treatment of refractory status epilepticus: a study of 31 episodes. Epilepsia. 2004;45(7):757–63. https://doi.org/10.1111/j.0013-9580.2004.01904.x.
Article CAS PubMed Google Scholar
Rossetti AO, Logroscino G, Bromfield EB. Refractory status epilepticus: effect of treatment aggressiveness on prognosis. Arch Neurol. 2005;62(11):1698–702. https://doi.org/10.1001/archneur.62.11.1698.
Article PubMed Google Scholar
Rossetti AO, Logroscino G, Milligan TA, Michaelides C, Ruffieux C, Bromfield EB. Status epilepticus severity score (STESS): a tool to orient early treatment strategy. J Neurol. 2008;255(10):1561–6. https://doi.org/10.1007/s00415-008-0989-1.
Article PubMed Google Scholar
Rossetti AO, Milligan TA, Vulliemoz S, Michaelides C, Bertschi M, Lee JW. A randomized trial for the treatment of refractory status epilepticus. Neurocrit Care. 2011;14(1):4–10. https://doi.org/10.1007/s12028-010-9445-z.
Article CAS PubMed Google Scholar
Rossetti AO, Alvarez V, Januel JM, Burnand B. Treatment deviating from guidelines does not influence status epilepticus prognosis. J Neurol. 2013;260(2):421–8. https://doi.org/10.1007/s00415-012-6644-x.
Article PubMed Google Scholar
Sabharwal V, Ramsay E, Martinez R, Shumate R, Khan F, Dave H, et al. Propofol-ketamine combination therapy for effective control of super-refractory status epilepticus. Epilepsy Behav. 2015;52(Pt A):264–6. https://doi.org/10.1016/j.yebeh.2015.07.040.
Article PubMed Google Scholar
Santamarina E, Toledo M, Sueiras M, Raspall M, Ailouti N, Lainez E, et al. Usefulness of intravenous lacosamide in status epilepticus. J Neurol. 2013;260(12):3122–8. https://doi.org/10.1007/s00415-013-7133-6.
Article CAS PubMed Google Scholar
Santamarina E, Gonzalez-Cuevas M, Toledo M, Jimenez M, Becerra JL, Quilez A, et al. Intravenous lacosamide (LCM) in status epilepticus (SE): weight-adjusted dose and efficacy. Epilepsy Behav. 2018;84:93–8. https://doi.org/10.1016/j.yebeh.2018.04.025.
Article PubMed Google Scholar
Sheth RD, Gidal BE. Intravenous valproic acid for myoclonic status epilepticus. Neurology. 2000;54(5):1201.
Article CAS Google Scholar
Shorvon S, Ferlisi M. The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol. Brain. 2011;134(Pt 10):2802–18. https://doi.org/10.1093/brain/awr215.
Article PubMed Google Scholar
Silbergleit R, Durkalski V, Lowenstein D, Conwit R, Pancioli A, Palesch Y, et al. Intramuscular versus intravenous therapy for prehospital status epilepticus. N Engl J Med. 2012;366(7):591–600. https://doi.org/10.1056/NEJMoa1107494.
Article CAS PubMed PubMed Central Google Scholar
Singhi S, Murthy A, Singhi P, Jayashree M. Continuous midazolam versus diazepam infusion for refractory convulsive status epilepticus. J Child Neurol. 2002;17(2):106–10. https://doi.org/10.1177/088307380201700203.
Article PubMed Google Scholar
Sorel L, Mechler L, Harmant J. Comparative trial of intravenous lorazepam and clonazepam im status epilepticus. Clin Ther. 1981;4(4):326–36.
CAS PubMed Google Scholar
Spatola M, Novy J, Du Pasquier R, Dalmau J, Rossetti AO. Status epilepticus of inflammatory etiology: a cohort study. Neurology. 2015;85(5):464–70. https://doi.org/10.1212/WNL.0000000000001717.
Article PubMed PubMed Central Google Scholar
Stojanova V, Rossetti AO. Oral topiramate as an add-on treatment for refractory status epilepticus. Acta Neurol Scand. 2012;125(2):e7–e11. https://doi.org/10.1111/j.1600-0404.2011.01562.x.
Article CAS PubMed Google Scholar
Strzelczyk A, Steinig I, Willems LM, Reif PS, Senft C, Voss M, et al. Treatment of refractory and super-refractory status epilepticus with brivaracetam: a cohort study from two German university hospitals. Epilepsy Behav. 2017a;70(Pt A):177–81. https://doi.org/10.1016/j.yebeh.2017.03.028.
Article PubMed Google Scholar
Strzelczyk A, Zollner JP, Willems LM, Jost J, Paule E, Schubert-Bast S, et al. Lacosamide in status epilepticus: systematic review of current evidence. Epilepsia. 2017b;58(6):933–50. https://doi.org/10.1111/epi.13716.
Article CAS PubMed Google Scholar
Sutter R, Kaplan PW, Ruegg S. Outcome predictors for status epilepticus – what really counts. Nat Rev Neurol. 2013a;9(9):525–34. https://doi.org/10.1038/nrneurol.2013.154.
Article PubMed Google Scholar
Sutter R, Marsch S, Ruegg S. Safety and efficacy of intravenous lacosamide for adjunctive treatment of refractory status epilepticus: a comparative cohort study. CNS Drugs. 2013b;27(4):321–9. https://doi.org/10.1007/s40263-013-0049-y.
Article CAS PubMed Google Scholar
Sutter R, Marsch S, Fuhr P, Kaplan PW, Ruegg S. Anesthetic drugs in status epilepticus: risk or rescue? A 6-year cohort study. Neurology. 2014;82(8):656–64. https://doi.org/10.1212/WNL.0000000000000009.
Article CAS PubMed PubMed Central Google Scholar
Swisher CB, Doreswamy M, Husain AM. Use of pregabalin for nonconvulsive seizures and nonconvulsive status epilepticus. Seizure. 2013;22(2):116–8. https://doi.org/10.1016/j.seizure.2012.11.004.
Article PubMed Google Scholar
Synowiec AS, Yandora KA, Yenugadhati V, Valeriano JP, Schramke CJ, Kelly KM. The efficacy of topiramate in adult refractory status epilepticus: experience of a tertiary care center. Epilepsy Res. 2012;98(2–3):232–7. https://doi.org/10.1016/j.eplepsyres.2011.09.017.
Article CAS PubMed Google Scholar
Thakur KT, Probasco JC, Hocker SE, Roehl K, Henry B, Kossoff EH, et al. Ketogenic diet for adults in super-refractory status epilepticus. Neurology. 2014;82(8):665–70. https://doi.org/10.1212/WNL.0000000000000151.
Article CAS PubMed PubMed Central Google Scholar
Towne AR, Garnett LK, Waterhouse EJ, Morton LD, DeLorenzo RJ. The use of topiramate in refractory status epilepticus. Neurology. 2003;60(2):332–4.
Article CAS Google Scholar
Treatment of convulsive status epilepticus. Recommendations of the Epilepsy Foundation of America’s Working Group on Status Epilepticus. JAMA. 1993;270(7):854–859.
Google Scholar
Treiman DM. Pharmacokinetics and clinical use of benzodiazepines in the management of status epilepticus. Epilepsia. 1989;30(Suppl 2):S4–10.
Article Google Scholar
Treiman DM, Meyers PD, Walton NY, Collins JF, Colling C, Rowan AJ, et al. A comparison of four treatments for generalized convulsive status epilepticus. Veterans affairs status epilepticus cooperative study group. N Engl J Med. 1998;339(12):792–8. https://doi.org/10.1056/NEJM199809173391202.
Article CAS PubMed Google Scholar
Trinka E. What is the evidence to use new intravenous AEDs in status epilepticus? Epilepsia. 2011;52(Suppl 8):35–8. https://doi.org/10.1111/j.1528-1167.2011.03232.x.
Article CAS PubMed Google Scholar
Trinka E, Hofler J, Zerbs A, Brigo F. Efficacy and safety of intravenous valproate for status epilepticus: a systematic review. CNS Drugs. 2014;28(7):623–39. https://doi.org/10.1007/s40263-014-0167-1.
Article CAS PubMed PubMed Central Google Scholar
Trinka E, Cock H, Hesdorffer D, Rossetti AO, Scheffer IE, Shinnar S, et al. A definition and classification of status epilepticus – report of the ILAE task force on classification of status epilepticus. Epilepsia. 2015a;56(10):1515–23. https://doi.org/10.1111/epi.13121.
Article PubMed Google Scholar
Trinka E, Hofler J, Leitinger M, Brigo F. Pharmacotherapy for status epilepticus. Drugs. 2015b;75(13):1499–521. https://doi.org/10.1007/s40265-015-0454-2.
Article CAS PubMed PubMed Central Google Scholar
Trinka E, Hofler J, Leitinger M, Rohracher A, Kalss G, Brigo F. Pharmacologic treatment of status epilepticus. Expert Opin Pharmacother. 2016;17(4):513–34. https://doi.org/10.1517/14656566.2016.1127354.
Article CAS PubMed Google Scholar
Twyman RE, Rogers CJ, Macdonald RL. Differential regulation of gamma-aminobutyric acid receptor channels by diazepam and phenobarbital. Ann Neurol. 1989;25(3):213–20. https://doi.org/10.1002/ana.410250302.
Article CAS PubMed Google Scholar
Ulvi H, Yoldas T, Mungen B, Yigiter R. Continuous infusion of midazolam in the treatment of refractory generalized convulsive status epilepticus. Neurol Sci. 2002;23(4):177–82. https://doi.org/10.1007/s100720200058.
Article CAS PubMed Google Scholar
van Vliet EA, Aronica E, Vezzani A, Ravizza T. Review: neuroinflammatory pathways as treatment targets and biomarker candidates in epilepsy: emerging evidence from preclinical and clinical studies. Neuropathol Appl Neurobiol. 2018;44(1):91–111. https://doi.org/10.1111/nan.12444.
Article PubMed Google Scholar
Vasile B, Rasulo F, Candiani A, Latronico N. The pathophysiology of propofol infusion syndrome: a simple name for a complex syndrome. Intensive Care Med. 2003;29(9):1417–25. https://doi.org/10.1007/s00134-003-1905-x.
Article PubMed Google Scholar
Walder B, Tramer MR, Seeck M. Seizure-like phenomena and propofol: a systematic review. Neurology. 2002;58(9):1327–32.
Article Google Scholar
Wasterlain CG, Baldwin R, Naylor DE, Thompson KW, Suchomelova L, Niquet J. Rational polytherapy in the treatment of acute seizures and status epilepticus. Epilepsia. 2011;52(Suppl 8):70–1. https://doi.org/10.1111/j.1528-1167.2011.03243.x.
Article CAS PubMed PubMed Central Google Scholar
Yasiry Z, Shorvon SD. The relative effectiveness of five antiepileptic drugs in treatment of benzodiazepine-resistant convulsive status epilepticus: a meta-analysis of published studies. Seizure. 2014;23(3):167–74. https://doi.org/10.1016/j.seizure.2013.12.007.
Article PubMed Google Scholar
Zeiler FA, Zeiler KJ, Teitelbaum J, Gillman LM, West M. Modern inhalational anesthetics for refractory status epilepticus. Can J Neurol Sci. 2015;42(2):106–15. https://doi.org/10.1017/cjn.2014.121.
Article PubMed Google Scholar
Zelano J, Kumlien E. Levetiracetam as alternative stage two antiepileptic drug in status epilepticus: a systematic review. Seizure. 2012;21(4):233–6. https://doi.org/10.1016/j.seizure.2012.01.008.
Article PubMed Google Scholar

Download references

Author information

Authors and Affiliations

Department of Clinical Neuroscience, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland
I. Beuchat & A. O. Rossetti

Authors

I. Beuchat
View author publications
You can also search for this author in PubMed Google Scholar
A. O. Rossetti
View author publications
You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. O. Rossetti .

Editor information

Editors and Affiliations

Dept Psychiatry , Psychosomatics & Psychotherapy, University of Würzburg, Medical School Clinical Neurochemistry, Würzburg, Germany
Peter Riederer
Inst für Psychologische Medizin, Haag, Bayern, Germany
Gerd Laux
Department of Psychiatry, University of Toronto Department of Psychiatry, Toronto, ON, Canada
Benoit Mulsant
Center Translational Res Neurol Diseases, Dalian Med Uni Shanghai Inst Health Sc Center Translational Res Neurol Diseases, Dalian, China
Weidong Le
Fujita Health University School Medicine, Toyoake, Aichi, Japan
Toshiharu Nagatsu

Section Editor information

Beta Neurology – Competence Center for Epilepsy, Beta Klinik GmbH, Bonn, Germany
Christian E. Elger

Rights and permissions

Reprints and permissions

Copyright information

About this entry

Cite this entry

Beuchat, I., Rossetti, A.O. (2020). Anticonvulsive Drug Use in Status Therapy: Adults. In: Riederer, P., Laux, G., Mulsant, B., Le, W., Nagatsu, T. (eds) NeuroPsychopharmacotherapy. Springer, Cham. https://doi.org/10.1007/978-3-319-56015-1_370-1

Download citation

DOI: https://doi.org/10.1007/978-3-319-56015-1_370-1
Received: 16 April 2020
Accepted: 17 April 2020
Published: 15 July 2020
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-56015-1
Online ISBN: 978-3-319-56015-1
eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics